Back to Search
HENRY NASRALLAH, MD
MD
Psychiatry Physician
NPI: 1346386307IndividualAccepts Medicare
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
35052113(OH)
CMS Specialties
PrimaryPSYCHIATRY
Education
OTHER
Class of 1972
Research & Publications (20)
Proceedings and data from The Schizophrenia Summit: a critical appraisal to improve the management of Schizophrenia.
PMID 19292973·J Clin Psychiatry·2009
8-other
Reliability, validity and ability to detect change of the Personal and Social Performance scale in patients with stable schizophrenia.
PMID 18848731·Psychiatry Res·2008
4-observational
The urgent need for monitoring and intervention to reduce metabolic risk factors in patients with schizophrenia.
PMID 18567979·CNS Spectr·2008
8-other
Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles.
PMID 17848919·Mol Psychiatry·2008
6-review
The case for long-acting antipsychotic agents in the post-CATIE era.
PMID 17355516·Acta Psychiatr Scand·2007
6-review
The roles of efficacy, safety, and tolerability in antipsychotic effectiveness: practical implications of the CATIE schizophrenia trial.
PMID 17286522·J Clin Psychiatry·2007
8-other
Introduction: evaluating the evidence: Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and beyond.
PMID 17286521·J Clin Psychiatry·2007
8-other
Improving patient outcomes in schizophrenia: achieving remission.
PMID 17046987·J Psychopharmacol·2006
6-review
Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
PMID 17042884·Bipolar Disord·2006
4-observational
Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline.
PMID 16884895·Schizophr Res·2006
4-observational
Metabolic findings from the CATIE trial and their relation to tolerability.
PMID 16816798·CNS Spectr·2006
8-other
Carbamazepine and valproate for the treatment of bipolar disorder: a review of the literature.
PMID 16780960·J Affect Disord·2006
4-observational
An overview of common medical comorbidities in patients with schizophrenia.
PMID 16107177·J Clin Psychiatry·2005
8-other
Defining and measuring clinical effectiveness in the treatment of schizophrenia.
PMID 15746501·Psychiatr Serv·2005
6-review
Atypical antipsychotics and metabolic dysregulation: evaluating the risk/benefit equation and improving the standard of care.
PMID 15356415·J Clin Psychopharmacol·2004
4-observational
Health-related quality of life in patients with schizophrenia during treatment with long-acting, injectable risperidone.
PMID 15119916·J Clin Psychiatry·2004
3-trial
Factors in antipsychotic drug selection: tolerability considerations.
PMID 14978455·CNS Spectr·2003
4-observational
A review of the effect of atypical antipsychotics on weight.
PMID 12504074·Psychoneuroendocrinology·2003
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 234 GOODMAN ST, PSYCHIATRY
CINCINNATI, OH 45219 - Phone
- (513) 558-7700
Quick Facts
- NPI
- 1346386307
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 54
- Publications
- 20
Are you this provider?
Claim Your Profile